AGTC Announces Topline Interim Six-Month Data from Phase 1/2 X-Linked Retinoschisis Clinical Study Life Science Investing
Naturally Splendid Provides Expanded Distribution Update of HempOmega™ Infused Beers Cannabis Investing News
What Does Early Data from BriaCell’s Bria-IMT Combination Study with KEYTRUDA Show? Biotech Investing
DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018 Pharmaceutical Investing
XBiotech’s Results from Phase 2 Atopic Dermatitis Study Suggest New Drug to Treat Skin Disease Life Science Investing
Zosano Receives Conditional FDA Acceptance of Proposed Brand Name Qtrypta for M207 Pharmaceutical Investing
Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency Pharmaceutical Investing
Aravive Biologics Initiates Phase 1b Portion of Phase 1b/2 Clinical Trial of AVB-S6-500 in Platinum-Resistant Recurrent Ovarian Cancer Pharmaceutical Investing
